1934
L.D. Jayanthi et al
Norepinephrine transporters in rat placenta
FRITZ, J., LANKUPALLE, J., THORESON, M.
&
BLAKELY, R.D.
PADBURY, J.F., TSENG, Y.-T., MCGONNIGAL, B., PENADO, K.,
STEPHAN, M. & RUDNICK, G. (1997). Placental biogenic amine
transporters: Cloning and expression. Mol. Brain Res., 45, 163 ±
168.
QIAN, Y., GALLI, A., RAMAMOORTHY, S., RISSO, S., DEFELICE, L.J.
& BLAKELY, R.D. (1997). Protein kinase C activation regulates
human serotonin transporters in HEK-293 cells via altered cell
surface expression. J. Neurosci., 17, 45 ± 47.
(1998). Cloning and chromosomal mapping of the murine
norepinephrine transporter. J. Neurochem, 70, 2241 ± 2251.
GALLI, A., BLAKELY, R.D. & DEFELICE, L.J. (1996). Norepinephrine
transporters have channel modes of conduction. Proc. Natl.
Acad. Sci. U.S.A., 93, 8671 ± 8676.
GALLI, A., BLAKELY, R.D. & DEFELICE, L.J. (1998). Patch-clamp
and amperometric recordings from norepinephrine transporters:
Channel activity and voltage-dependent uptake. Proc. Natl.
Acad. Sci. U.S.A., 95, 13260 ± 13265.
GALLI, A., DEFELICE, L.J., DUKE, B.J., MOORE, K.R. & BLAKELY,
R.D. (1995). Sodium-dependent norepinephrine-induced currents
in norepinephrine transporter transfected HEK-293 cells blocked
by cocaine and antidepressants. J. Exp. Biol., 198, 2197 ± 2212.
RAMAMOORTHY, J.D., RAMAMOORTHY, S., LEIBACH, F.H.
&
GANAPATHY, V. (1995). Human placental monoamine transpor-
ters as targets for amphetamines. Am. J. Obstet. Gynecol., 173,
1782 ± 1787.
RAMAMOORTHY, S., PRASAD, P.D., KULANTHAIVEL, P., LEI-
BACH, F.H., BLAKELY, R.D.
& GANAPATHY, V. (1993).
GANGULY, P.K., DHALLA, K.S., INNES, I.R., BEAMISH, R.E.
&
Expression of a cocaine-sensitive norepinephrine transporter in
the human placental syncitiotrophoblast. Biochemistry, 32,
1346 ± 1353.
DHALL, N.S. (1986). Altered norepinephrine turnover and
metabolism in diabetic cardiomyopathy. Circ. Res., 59, 684 ± 693.
IVERSEN, L.L. (1978). Uptake processes for biogenic amines. In
Handbook of Psychopharmacology. ed. Iversen, I. pp. 381 ± 442.
New York: Prenum Press.
JAYANTHI, L.D., PRASAD, P.D., RAMAMOORTHY, S., MAHESH,
V.B., LEIBACH, F.H. & GANAPATHY, V. (1993). Sodium- and
chloride-dependent, cocaine-sensitive, high-anity binding of
nisoxetine to the human placental norepinephrine transporter.
Biochemistry, 32, 12178 ± 12185.
JAYANTHI, L.D., RAMAMOORTHY, S., MAHESH, V.B., LEIBACH,
F.H. & GANAPATHY, V. (1994). Calmodulin-dependent regula-
tion of the catalytic function of the human serotonin transporter
in placental choriocarcinoma cells. J. Biol. Chem., 269, 14424 ±
14429.
KAYE, D.M., WIVIOTT, S.D., KOBZIK, L., KELLY, R.A. & SMITH,
T.W. (1997). S-nitrosothiols inhibit neuronal norepinephrine
transport. Am. J. Physiol., 272, H875 ± H883.
SEYFARTH, M., RICHARDT, G., MIZSNYAK, A., KURZ, T.
&
SHOMIG, A. (1996). Transient ischemia reduces norepinephrine
release during sustained ischemia. Neural preconditioning in
isolated rat heart. Circ. Res., 78, 573 ± 580.
SHAFQAT, S., VELAZ-FAIRCLOTH, M., GUADANO-FERRAZ, A. &
FREMEAU, R.T. (1993). Molecular characterization of neuro-
transmitter transporters. Mol. Endocrinol., 7, 1517 ± 1529.
SHANNON, J.R., FLATTEM, N.L., JORDAN, J., JACOB, G., BLACK,
B.K., BIAGGIONI, I., BLAKELY, R.D. & ROBERTSON, D. (2000).
Orthostatic intolerance and tachycardia associated with norepi-
nephrine-transporter de®ciency. N. Engl. J. Med., 342, 541 ± 549.
SHEARMAN, L.P., MCREYNOLDS, A.M., ZHOU, F.C. & MEYER, J.S.
(1998). Relationship between [125I]RTI-55-labeled cocaine
binding sites and the serotonin transporter in rat placenta. Am.
J. Physiol., 275, C1621 ± C1629.
SHEARMAN, L.P. & MEYER, J.S. (1998). Norepinephrine transpor-
ters in rat placenta labeled with [3H]nisoxetine. J. Pharmacol.
Exp. Ther., 284, 736 ± 743.
KITAYAMA, S., IKEDA, T., MITSUHATA, C., SATO, T., MORITA, K. &
DOHI, T. (1999). Dominant negative isoform of rat norepinephr-
ine transporter produced by alternative RNA splicing. J. Biol.
Chem., 274, 10731 ± 10736.
SHEARMAN, L.P.
& MEYER, J.S. (1999). Cocaine up-regulates
norepinephrine transporter binding in the rat placenta. Eur. J.
Pharmacol., 386, 1 ± 6.
KLIMAN, H.J., NESTLER, J.E., SERMASI, E., SANGER, J.M.
&
STRAUSS, III, J.F. (1986). Puri®cation, characterization, and in
vitro dierentiation of cytotrophoblasts from human term
placentae. Endocrinology, 118, 1567 ± 1582.
SUMNERS, C. & RAIZADA, M.K. (1986). Angiotensin II stimulates
norepinephrine uptake in hypothalamus-brain stem neuronal
cultures. Am. J. Physiol., 250, C236 ± C244.
LINGEN, B., BRUSS, M.
&
BONISCH, H. (1994). Cloning and
TATSUMI, M., GROSHAN, K., BLAKELY, R.D. & RICHELSON, E.
(1997). Pharmacological pro®le of antidepressants and related
compounds at human monoamine transporters. Eur. J. Pharma-
col., 340, 249 ± 258.
expression of the bovine sodium- and chloride-dependent
noradrenaline transporter. FEBS, 342, 235 ± 238.
MELIKIAN, H.E., MCDONALD, J.K., GU, H., RUDNICK, G., MOORE,
K.R. & BLAKELY, R.D. (1994). Human norepinephrine transpor-
ter: Biosynthetic studies using a site-directed polyclonal anti-
body. J. Biol. Chem., 269, 12290 ± 12297.
THOMAS, S.A., MATSUMOTO, A.M.
& PALMITER, R.D. (1995).
Noradrenaline is essential for mouse fetal development. Nature,
374, 643 ± 646.
MEREDITH, I.T., EISENHOFER, G., LAMBERT, G.W., DEWAR, E.M.,
JENNINGS, G.L. & ESLER, M.D. (1993). Cardiac sympathetic
nervous activity in congestive heart failure. Evidence for
increased neuronal norepinephrine release and preserved neuro-
nal uptake. Circulation, 88, 136 ± 145.
PACHOLCZYK, T., BLAKELY, R.D. & AMARA, S.G. (1991). Expres-
sion cloning of a cocaine- and antidepressant-sensitive human
noradrenaline transporter. Nature, 350, 350 ± 354.
VATTA, M.S., BIANCIOTTI, L.G. & FERNANDEZ, B.E. (1993).
In¯uence of atrial natriuretic factor on uptake, intracellular
distribition, and release of norepinephrine in rat adrenal medulla.
J. Physiol. and Pharmacol., 71, 195 ± 200.
ZHOU, Q.-Y., QUALFE, C.J. & PALMITER, R.D. (1995). Targeted
disruption of the tyrosine hydroxylase gene reveals that
catecholamines are required for mouse fetal development.
Nature, 374, 640 ± 643.
(Received January 10, 2002
Revised February 5, 2002
Accepted February 8, 2002)
British Journal of Pharmacology vol 135 (8)